KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Non-cash Items: 2018-2019

  • Amneal Pharmaceuticals' Non-cash Items fell 20.30% to $2.1 million in Q4 2019 from the same period last year, while for Dec 2019 it was $2.1 million, marking a year-over-year decrease of 20.30%. This contributed to the annual value of $2.1 million for FY2019, which is 20.30% down from last year.
  • According to the latest figures from Q4 2019, Amneal Pharmaceuticals' Non-cash Items is $2.1 million, which was down 20.30% from $2.6 million recorded in Q4 2018.
  • Amneal Pharmaceuticals' 5-year Non-cash Items high stood at $2.6 million for Q4 2018, and its period low was $2.1 million during Q4 2019.
  • Moreover, its 2-year median value for Non-cash Items was $2.3 million (2018), whereas its average is $2.3 million.
  • Data for Amneal Pharmaceuticals' Non-cash Items shows a maximum YoY decreased of 20.30% (in 2019) over the last 5 years.
  • Amneal Pharmaceuticals' Non-cash Items (Quarterly) stood at $2.6 million in 2018, then decreased by 20.30% to $2.1 million in 2019.